De novo cataract development following a standard course of hyperbaric oxygen therapy

Undersea and Hyperbaric Medicine

Volumn 34, Issue 6, 2007, Pages 389-392

  Gesell, L B ^a   Trott, A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CATARACT; FEMALE; HUMAN; HYPERBARIC OXYGEN; MIDDLE AGED; OSTEOMYELITIS; SACRUM;

CATARACT; FEMALE; HUMANS; HYPERBARIC OXYGENATION; MIDDLE AGED; OSTEOMYELITIS; SACRUM;

EID: 38949143691     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fledelius HC, Jansen EC, Thorn J. Refractive change during hyperbaric oxygen therapy. A clinical trial using ultrasound oculometry. Acta Ophthalmol Scand 2002; 80:188-190.
2. Lyne AJ. Ocular effects of hyperbaric oxygen. Trans Ophthalmol Soc UK 1978; 98:66-68.
3. Ross ME, Yolton DP, Yolton RL, Hyde KD. Myopia associated with hyperbaric oxygen therapy. Optometry Vision Science 1996; 73:487-494.
4. Anderson B, Farmer JC. Hyperoxic myopia. Tr Am Ophth Soc 1978; 76:116-122.
5. Giblin FJ, Padgaonkar VA, Leverenz VR, et al. Nuclear light scattering, disulfide formation and membrane damage in lenses of older guinea pigs treated with hyperbaric oxygen. Exp Eye Res 1995; 60:219-235.
6. Padgaoankar VA, Leverenz VR, Fowler KE, Reddy VN, Giblin FJ. The effects of hyperbaric oxygen on the crystallins of cultured rabbit lenses: a possible catalytic role of copper. Exp Eye Res 2000; 71:371-383.
7. Palmquist BM, Philipson B, Barr PO. Nuclear cataract and myopia during hyperbaric oxygen therapy. Br J Ophthalmol 1984; 68:113-117.
8. Kindwall EP. Contraindications and side effects to hyperbaric oxygen treatment. In Kindwall EP, Whelan HT. Hyperbaric medicine practice, rev ed. Flagstaff AZ: Best Publishing Co., 2002:83-97.
9. Solomon R, Donnenfeld ED. Recent advances and future frontiers in treating age-related cataracts. JAMA 2003;290:248-251.
10. Allen D, Vasavada A. Cataract and surgery for cataract. BMJ 2006; 333:128-132.
11. Truscott RJW. Age-related nuclear cataract-oxidation is the key. Exp Eye Res 2005; 80:709-725.
12. Giblin FJ. Glutathione: a vital lens antioxidant. J Ocul Pharmacol Ther 2000; 16:121-135.
13. Padgoankar VA, Lin L, Leverenz AR, Rinke A, Reddy VN, Giblin FJ. Hyperbaric oxygen in vivo accelerates the loss of cytoskeletal proteins and MIP26 in guinea pig lens nucleus. Exp Eye Res 1999; 68:493-504.
14. Schoket SS, Esterson J, Bradford B, Michaelis M, Richards RD. Induction of cataracts in mice to oxygen exposure. Isr J Med Sci 1972; 8:1596-1601.
15. Mukesh BN, Le A, Dimitrov PN, Ahmed S, Taylor HR, McCarty CA. Development of cataract and associated risk factors: the Visual Impairment Project. Arc Ophthakmol 2006; 124:79-85.
16. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15:202-5.
17. Kaushal S, Garg KC. Uncommon association - pre-senile cataract with scleroderma. J Assoc Physicians India 1985; 33:244-245.